| 2025-11-12 |
详情>>
股本变动：
变动后总股本1582.68万股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.76美元,归母净利润-369.49万美元,同比去年增长-292.69%
|
| 2025-10-24 |
股东大会：
将于2025-12-08召开股东大会
会议内容 ▼▲
- 1.To elect four directors to serve until the next annual meeting of shareholders and until their respective successors shall have been duly elected and qualified;
2.To consider and vote, on a non-binding, advisory basis, upon the compensation of those of our executive officers listed in the Summary Compensation Table appearing elsewhere in this proxy statement, or our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K;
3.To ratify the selection of Astra Audit & Advisory, LLC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025;
4.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d) (“Nasdaq Rule 5635(d)”), the issuance of shares of Company common stock, $0.001 par value (“Common Stock”), upon exercise of all the common stock purchase warrants (including the issuance of shares of Common Stock upon the operation of anti-dilution and other adjustment provisions contained in such warrants), issued pursuant to the terms of that certain Securities Purchase Agreement, dated January 21, 2025, by and among the Company and the investors named therein, in an amount equal to or in excess of 20% of the number of outstanding shares of Common Stock, at prices below the Minimum Price (defined below);
5.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Rule 5635(d) (“Rule 5635(d)”), the issuance of shares of our Common Stock, upon exercise of the Company’s Series A common stock purchase warrants (the “Series A Warrants”), issued to certain holders (each, a “Holder”) pursuant to certain warrant inducement agreements, dated as of September 17, 2025, by and between the Company and each Holder (including the issuance of shares of Common Stock upon the operation of anti-dilution and other adjustment provisions contained in such warrants), in an amount equal to or in excess of 20% of the number of outstanding shares of Common Stock, at prices below the Minimum Price;
6.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Rule 5635(d), the issuance of shares of our Common Stock upon (i) conversion of up to $1,500,000 in convertible promissory notes and (ii) exercise of common stock purchase warrants to purchase up to 30,000,000 shares of Common Stock to be issued by us (including any amortization payments made to the holders of such convertible promissory notes in the form of issuance of shares of Common Stock and upon the operation of anti-dilution and other adjustment provisions contained in such convertible promissory notes and warrants), on substantially the same terms as the convertible promissory notes and common stock purchase warrants issued pursuant to the Securities Purchase Agreement, dated January 21, 2025, except for the terms described herein, to be entered into pursuant to the terms of a Securities Purchase Agreement at a future date (the “Issuance Proposal”), by and among the Company and the investors named therein, in an amount equal to or in excess of 20% of our Common Stock outstanding before entering into such Agreement for the issuance of such stock and warrants and at prices below the Minimum Price;
7.To consider and vote upon a proposed amendment of the Company’s certificate of incorporation to increase the number of authorized shares 45,000,000 shares to155,000,000 shares, of which 150,000,000 shares will be authorized Common Stock;
8.To consider and vote upon the Company’s 2025 Equity Incentive Plan;
9.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.78美元,归母净利润-238.24万美元,同比去年增长-361.73%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.25美元,归母净利润-47.63万美元,同比去年增长-166.6%
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-0.78美元,归母净利润-113.62万美元,同比去年增长71.46%
|
| 2024-12-02 |
股东大会：
将于2024-12-23召开股东大会
会议内容 ▼▲
- 1.To elect four directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To consider and vote, on a non-binding, advisory basis, upon the compensation of those of our executive officers listed in the Summary Compensation Table appearing elsewhere in this proxy statement, or our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K;
3.To ratify the selection of Astra Audit & Advisory, LLC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024;
4.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, par value $0.001 per share (“Common Stock”) upon (i) conversion of convertible promissory notes and (ii) exercise of common stock purchase warrants issued by us (including any amortization payments made to the holders of convertible promissory notes in the form of the issuance of shares of Common Stock and upon the operation of anti-dilution and other adjustment provisions contained in such convertible promissory notes and warrants), in each case pursuant to the terms of that certain Securities Purchase Agreement, dated July 16, 2024 (the “Issuance Proposal”), by and among the Company and the investors named therein in an amount equal to or in excess of 20% of our Common Stock outstanding before the issuance of such stock and warrants and at prices below the “Minimum Price” as defined below;
5.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock pursuant to a certain settlement agreement dated July 15, 2024 (the “Settlement Agreement”) in an amount which may be equal to or in excess of 20% of our Common Stock outstanding before the issuance of such stock and at prices below the Minimum Price;
6.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of Common Stock pursuant to the exercise of common stock purchase warrants issued by us (including the issuance of shares of Common Stock upon the operation of anti-dilution and other adjustment provisions contained in such warrants) pursuant to the terms of that certain Securities Purchase Agreement, dated November 19, 2024 (the “Private Investment”), by and among the Company and the investors named therein in an amount, which when coupled with shares of common stock issued in the Private Offering, will be equal to or in excess of 20% of our Common Stock outstanding as of July 16, 2024 and at prices below the Minimum Price;
7.To consider and vote upon a proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our Common Stock upon (i) conversion of up to $1,500,000 of convertible promissory notes and (ii) exercise of common stock purchase warrants to purchase up to 1,500,000 shares of Common Stock to be issued by us (including any amortization payments made to the holders of such convertible promissory notes in the form of issuance of shares of Common Stock and upon the operation of anti-dilution and other adjustment provisions contained in such convertible promissory notes and warrants) on the same terms as the convertible promissory notes and common stock purchase warrants issued pursuant to the Securities Purchase Agreement, dated July 16, 2024, except for the terms described herein, to be entered into on a date within 60 days of the Annual Meeting (the “Second Issuance Proposal”), in an amount equal to or in excess of 20% of our Common Stock outstanding as of July 16, 2024 and at prices below the Minimum Price;
8. To consider and vote upon a proposed amendment of the Company’s certificate of incorporation to effect a reverse stock split of the Company’s Common Stock at a ratio to be determined by our board of directors, in its discretion, but within the range of 1/2 and 1/15, if the minimum bid price of $1.00 is not maintained and the company receives a notice of deficiency from Nasdaq;
9.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-11-21 |
复牌提示：
2024-11-21 09:44:34 停牌，复牌日期 2024-11-21 09:49:34
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.69美元,归母净利润-94.09万美元,同比去年增长33.36%
|
| 2024-10-11 |
详情>>
业绩披露：
2024年中报每股收益-0.41美元,归母净利润-51.6万美元,同比去年增长6.83%
|
| 2024-10-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.14美元,归母净利润-17.87万美元,同比去年增长55.32%
|
| 2024-09-24 |
详情>>
业绩披露：
2023年年报每股收益-3.86美元,归母净利润-398.11万美元,同比去年增长-115.5%
|
| 2024-05-15 |
详情>>
内部人交易：
IRBY ALTON F III等共交易7笔
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.1美元,归母净利润-141.21万美元,同比去年增长11.16%
|
| 2023-10-11 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2023-08-18 |
股东大会：
将于2023-10-06召开股东大会
会议内容 ▼▲
- 1.To elect three directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To consider and act upon a proposed amendment of the Company’s certificate of incorporation to effect a 1:__[TBD] reverse stock split of the Company’s Common Stock;
3.To consider and vote, on a non-binding, advisory basis, upon the compensation of those of our executive officers listed in the Summary Compensation Table appearing elsewhere in this proxy statement, or our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K;
4.To ratify the selection of BF Borgers CPA PC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023;
5.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.04美元,归母净利润-55.38万美元,同比去年增长53.46%
|
| 2022-11-07 |
股东大会：
将于2022-12-22召开股东大会
会议内容 ▼▲
- 1.To elect four directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To ratify the selection of BF Borgers CPA PC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2022;
3.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-11-12 |
股东大会：
将于2021-12-22召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To ratify the selection of BFBorgers CPA PC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2021;
3.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-11-04 |
股东大会：
将于2021-12-20召开股东大会
会议内容 ▼▲
- 1.To elect five directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To ratify the selection of BFBorgers CPA PC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2021;
3.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-05-24召开股东大会
会议内容 ▼▲
- 1.To elect four directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;An amendment to the Company’s 2016 Stock Option Plan to increase the number of shares of common stock available for issuance thereunder to 5,000,000 shares of common stock, on a post-split adjusted basis (the “Stock Option Plan Proposal”), as required by the Internal Revenue Code and Nasdaq Rule 5635(c).
2.To consider and vote, on a non-binding, advisory basis, upon the compensation of those of our executive officers listed in the Summary Compensation Table appearing elsewhere in this proxy statement, or our named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K;
3.To ratify the selection of BF Borgers CPA PC as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2020;
4.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-12-03 |
股东大会：
将于2019-12-30召开股东大会
会议内容 ▼▲
- 1.To elect four directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified;
2.To ratify the selection of WithumSmith + Brown as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2019;
3.To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-02-04 |
详情>>
拆分方案：
每19.0000合并分成1.0000股
|
| 2019-01-17 |
股东大会：
将于2019-01-30召开股东大会
会议内容 ▼▲
- 1.AMMA’s acquisition of SCWorx Corp., a Delaware corporation (“SCWorx”), pursuant to that certain share exchange agreement dated as of August 20, 2018 (the “Acquisition”) by and among AMMA, SCWorx and the stockholders of SCWorx, as amended by Amendment No. 1 thereto (the “Share Exchange Agreement” or “SEA”), as required by Nasdaq Rule 5635(a), and the resulting change of control of AMMA due to the issuance of AMMA shares to the stockholders of SCWorx in connection with the Acquisition, as required by Nasdaq Rule 5635(b) (the “Share Exchange Proposal”).
2.The issuance of units, at a per unit price of $10, comprised in the aggregate of (i) up to 900,000 shares of Preferred Stock, face value $10 per share, convertible, upon stockholder approval, into common stock at a rate of $0.20 per share (subject to adjustment), and (ii) warrants to purchase up to 22,500,000 shares of common stock, with an exercise price of $0.30 per share (subject to adjustment) (the “Preferred Stock Units”), for aggregate consideration of up to $9,000,000, as a below market issuance (on an as converted basis) of more than 20% of the then issued and outstanding common shares of AMMA, as required by Nasdaq Rule 5635(d) (the “Financing Proposal”). The Preferred Stock and Warrants are expected to be issued in consideration of: (i) up to $6 million in cash and (ii) satisfaction of (a) approximately $1.9 million in indebtedness of SCWorx in connection with consummation of the Acquisition and (b) up to $1.1 million of indebtedness of AMMA.
3.An amendment to the certificate of incorporation of AMMA to effect a reverse stock split of AMMA common stock sufficient in the judgment of the Board of Directors to result in a minimum bid price of AMMA’s common stock of at least $4.00 per share at the closing of the Acquisition (the “Stock Split Proposal”) (the reverse stock split ratio is anticipated to be in the range of between 1/15 and 1/25 where the numerator is the number of new shares being issued and the denominator is the number of shares outstanding for which such number of new shares is being issued). By way of illustration, if the reverse split ratio is 1/15, then 1 new share will be issued in replacement for every 15 shares outstanding, so that if there were 15 million shares outstanding pre-split, there would be 1 million shares outstanding post-split. Stockholder approval of the Stock Split Proposal is required by the Delaware General Corporation Law. Although the Board of Directors anticipates that the reverse stock split ratio will be in the range of between 1/15 and 1/25, the actual reverse stock split ratio will be determined by the Board of Directors and may be significantly higher or lower than such anticipated range. All references to shares of AMMA common stock in the Proxy Statement refer to pre-split shares, except as otherwise noted.
4.An amendment to AMMA’s 2016 Stock Option Plan to increase the number of shares of common stock available for issuance thereunder to 3,000,000 shares of common stock, on a post-split adjusted basis (the “Stock Option Plan Proposal”), as required by the Internal Revenue Code and Nasdaq Rule 5635(c).
5.To elect four (4) members of the Board of Directors of AMMA, all of whom are current directors, to hold office until the next annual meeting or until their respective successors are duly elected and qualified.
6.To ratify the appointment of Friedman LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2018 (the “Auditor Ratification Proposal”).
7.To consider and approve by a nonbinding advisory vote, the compensation of our named executive officers as described in the accompanying proxy statement;
8.To recommend, by a nonbinding advisory vote, the frequency (every one, two or three years) of future advisory votes of stockholders on the compensation of our named executive officers;
|
| 2017-08-03 |
股东大会：
将于2017-09-01召开股东大会
会议内容 ▼▲
- 1.to elect six (6) members of the Company’s Board of Directors to hold office until the next annual meeting or until their respective successors are duly elected and qualified;
2.to ratify the appointment of Friedman LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2017;
3.to approve the Company’s Amended and Restated 2016 Equity Incentive Plan;
4.to consider and act on such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|